Vontobel Holding
KRYS icon

Vontobel Holding’s Krystal Biotech KRYS Stock Holding History

Vontobel Holding’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$106K – 1483
2025
Q3 		$106K Buy
+600
New +$89.8K ﹤0.01% 1284

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vontobel Holding's KRYS Position: Q2 2026 in Review

Vontobel Holding reduced its Krystal Biotech (KRYS) stake by 34% in Q2 2026, selling an estimated $214K and leaving 1,402 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

Vontobel Holding first reported a position in KRYS in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.06M in Q1 2021. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Vontobel Holding held 1,402 shares of Krystal Biotech worth $521K as of Q2 2026.
  • Vontobel Holding sold 716 Krystal Biotech shares in Q2 2026, an estimated $214K.
  • Krystal Biotech made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1034 holding.
  • Vontobel Holding first reported a position in Krystal Biotech in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Krystal Biotech position peaked at $3.06M in Q1 2021.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.